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Microarray technology provides an opportunity to view transcriptions at genomic level under diﬀerent conditions controlled
by an experiment. From an array experiment using a human cancer cell line that is engineered to diﬀer in expression of tumor
antigen, integrin α6β4, few hundreds of diﬀerentially expressed genes are selected and are clustered using one of several standard
algorithms. The set of genes in a cluster is expected to have similar expression patterns and are most likely to be coregulated and
thereby expected to have similar function. The highly expressed set of upregulated genes become candidates for further evaluation
aspotentialbiomarkers.Besidesthesebeneﬁts,microarrayexperimentbyitselfdoesnothelpustounderstandordiscoverpotential
pathways or to identify important set of genes for potential drug targets. In this paper we discuss about integrating protein-
to-protein interaction information, pathway information with array expression data set to identify a set of “important” genes,
and potential signal transduction networks that help to target and reverse the oncogenic phenotype induced by tumor antigen
such as integrin α6β4. We will illustrate the proposed method with our recent microarray experiment conducted for identifying
transcriptional targets of integrin α6β4 for cancer progression.
Copyright © 2009 R. Loganantharaj and J. Chung. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
A micro-array experiment is conducted to study expression
proﬁles of genes in a specimen under diﬀerent experimental
conditions, or over several diﬀerent time periods. It serves
many purposes that include (1) developing a predictive com-
putational model which can be used to predict biomarkers
and targets for cancer therapy, (2) gaining some insight on
gene regulation when a microarray experiment is conducted
in diﬀerent time points, (3) gaining insight on the genes that
may be involved in a situation or disease under investigation,
(4) understanding or reﬁning protein-in-protein interaction
networks, and (5) annotating uncharacterized genes. In
a recent review article on the applications of microarray,
Troyanskaya [1] provides some details on the items 2, 4, and
5.Statistical testsareconductedto ﬁltervalid signals ﬁrstand
then a subset of genes called diﬀerentially expressed genes
is selected based on their relative strength or weakness of
expression levels with respect to their reference expression
values. The diﬀerentially expressed probes, which roughly
correspond to genes, are reduced to few hundreds while the
t o t a ln u m b e ro fp r o b e so fa ne x p e r i m e n ti si nt h eo r d e ro f2 0
to 50 thousands.
The set of highly expressed genes are considered to
be candidates for biomarkers in a microarray experiment.
It is quite diﬃcult to single out the best biomarkers
by viewing expression level alone partially due to noise
or some association by “guilt.” By integrating microarray
expression data with other information pertaining to the
protein behavior we can improve the quality of decision
on biomarkers as has been proposed by Camargo and
Azuaje in [2]. Similarly we vcan gain better insight into
gene regulation by associating gene expression with protein
interaction network with known cancer related pathways.
A signiﬁcant volume of works has been done that relates
or combines microarray data sets and protein-to-protein2 Journal of Biomedicine and Biotechnology
Table 1: The high ranking 14 up regulated genes based on the fold
changes. For each gene in the list the connectivity in the protein
interaction network G is given. None of the ranked upregulated
genes are hub nodes.
Genes Fold changes Connectivity in G
IL8 5.63 11
S100A3 4.86 4
SOX4 4.54 2
SLCO4A1 4.12 2
MAGEH1 3.77 9
AKR1C1 3.72 2
MAD1L1 3.45 21
IL24 3.35 1
HSPA6 3.25 13
NRCAM 3.18 10
COL6A1 3.07 5
ASPH 3.03 2
TUSC3 2.98 1
PEG10 2.87 1
interaction networks. Based on the expected outcome, these
works may be characterized into (1) annotating unchar-
acterized genes, (2) reﬁning protein-to-protein interaction
network, (3) predicting protein to protein interaction, and
(4) reﬁning potential biomarkers from array expression.
Integrating protein interaction network information with
expression data sets along with other information pertaining
toagenehasbeenused[3–7]forannotatinguncharacterized
protein. In the recent work of Nariai et al. [6], probabilistic
approach has been used to integrate protein to protein
interaction, array expression, protein motif, gene knockout
phenotype data, and protein localization data for predicting
the function of an uncharacterized genes.
Microarray expressions data has also been used for
reﬁning protein to protein interaction networks. Zhu et al.
[8] have used coexpressed genes from microarray data set
to ﬁlter the neighbors of protein in an interaction network
to enhance the degree of functional consensus among the
neighbors.
Array expression data sets are used for predicting protein
to protein interaction [9, 10]. Recently Soong et al. [10]
haveusedmicroarrayexpressiontopredictproteintoprotein
interaction. A pair of proteins is represented by a feature
vector consisting of a concatenation of expression modes or
proﬁles of those proteins along with the Pearson correlation
of the expression proﬁles of these two proteins. They have
demonstrated the predictability of using support vector
machine with protein to protein interaction of yeast data sets
from DIP [11] and 349 yeast microarray expression data sets
from GEO [12].
Camargo et al. [12] have integrated array expression data
set with expression data for reﬁning potential biomarkers.
Their work has some overlapping with our current approach
in selecting hub nodes from interaction network and com-
bining with array expression data sets. Their focus, however,
was only on reﬁning the biomarkers derived from array
expression as opposed to providing insight into potential
signal transduction pathways or any other intermediate
activities that are not revealed in an array expression.
We take a diﬀerent approach that compliments the
strength of interaction data sets and array expression data
sets. The array data sets capture the expression levels at
diﬀerent experimental conditions (or time points) while the
information on interaction networks represents experimen-
tally determined and as well as predicted interaction between
pairs of proteins in a two-dimensional space without paying
attention to the context, the temporal relations, or the
process. By bringing two diﬀerent types of modalities of
information together, we believe we can discover some
important genes that may have played important roles in the
ﬁnal observation of the array expression.
Suppose we consider a binary case of studying the
expression pattern of a cell line of healthy and sick subjects.
Examining the diﬀerentially expressed genes provides infor-
mation on which genes are up-or downregulated, and their
expression levels. This information alone does not provide
insight into deciding interesting set of genes that are either
taking part of the progression or the cause of the disease
under consideration. We will show how to integrate gene
expression with expression patterns with protein to protein
interaction, and known genes in disease pathways to gain
insight onto a small subset of interesting genes relevant to
the disease under investigation.
To illustrate and to apply the idea of integrating microar-
ray data with protein to protein interaction network, and
disease related pathways, we use our recent microarray
study for identifying transcriptional targets of integrin α6β4
for cancer progression. Jun Chung and his associates have
used the aﬀymetrix HG-U133A 2 to identify transcriptional
targets of integrin α6β4. The goal of the study is to
identify α6β4 transcriptional targets important for breast
cancer progression. The α6β4 integrin, an epithelial-speciﬁc
integrin, functions as a receptor for the members of the
laminin family of extra cellular matrix proteins [13, 14].
While the primary known function of α6β4i st oc o n t r i b u t e
totissueintegritythroughitsabilitytomediatetheformation
of hemidesmosomes (HDs), there is growing evidence
suggesting that this integrin also plays a pivotal role in
functions associated with cancer progression [13, 14]. For
example, high expression of this integrin in women with
breast cancer has been shown to correlate signiﬁcantly with
mortality and disease states [13, 14]. However, therapeutic
targets of breast cancer that overexpress α6β4a r en o ty e t
well characterized. For this reason, it is essential to elucidate
the mechanism by which α6β4 contributes to breast cancer
progression.
We describe the data set, methods, and approaches in
Section 2. It is followed by results in Section 3.I nSection 4,
we summarize and discuss the results.
2.MaterialsandMethods
2.1. Data. We are focusing on genes of Homo sapiens and
their expressions for this experiment. From Aﬀymetrix siteJournal of Biomedicine and Biotechnology 3
Table 2: The high ranking 14 downregulated genes. For each gene
in the list, the connectivity in the protein interaction network G is
given. The 5 hub nodes among the ranked down regulated genes are
underlined.
Genes Fold change (inverse) Connectivity in G
HBE1 9.10 1
H1F0 7.70 7
AZGP1 7.64 3
SNCA 5.24 44
GLUL 5.13 31
TPM1 4.62 17
IGFBP7 4.54 10
MYLK 4.25 28
KCNS3 4.23 1
NGFRAP1 4.12 15
DGKI 3.97 1
IL1RAP 3.92 14
THBS1 3.70 36
MAP1B 3.65 1
at http://www.aﬀymetrix.com/, we have downloaded the
annotations (HG-U133A 2.na22.annot) for the genes that
are tested in a microarray experiment.
The gene expression data is from our recent microarray
experiment using the aﬀymetrix HG-U133A 2t oi d e n t i f y
transcriptional targets of integrin α6β4. Our study here
describes the gene expression proﬁle obtained from MDA-
MB-435 mock transfectants (α6β4 negative human cancer
cell line) and MDA-MB-435 β4 integrin transfectants (α6β4
positive human cancer cell lines). Out of oligonucleotide
probe sets representing approximately 22277 genes, expres-
sion of β4 integrin in MDA-MB-435 cells up regulated 149
genes by twofold or higher. 193 genes are down regulated
by over two fold change. We anticipate that microarray data
will lead to not only the identiﬁcation of α6β4t a r g e tg e n e s
thatareimportantforbreastcancercellgrowth,survival,and
invasion, butalsothe discoveryofsignaling pathwaysleading
to the expression of these genes.
The protein to protein interaction databases include
MIPS [15], DIP [11], BIND [16, 17], GRID and I2D [18].
Noise is often a factor in many protein to protein interaction
dataset. To minimize the noise and its impacts on the ﬁnal
outcome, we apply ensemble-based method for selecting
the interaction. That is, by applying majority voting on
interacting pairs from diﬀerent the database, we can improve
the accuracy and minimize the errors in their interaction
information. I2D provides experimentally determined and
predicted protein to protein interaction with easy to use
interface, and thus we have downloaded I2D [18]f o rh o m o
sapiens genome.
2.2. Data Preprocessing. Suppose we are gathering protein
to protein interaction from diﬀerent sources each with their
own accuracy. By combining the results of independent
test or source that has prediction accuracy over 50%, we
can obtain prediction accuracy better than any one method
alone. Suppose we have n independent sources each with
some predeﬁned ﬁxed prediction accuracy, say p. Without
loss of generality, let us assume n is an odd number. By
accepting the decision of majority predictors among n, the
combined accuracy is given by the following formula:
prediction accuracy =
i=n  
i=k
⎛
⎝
n
i
⎞
⎠pi 
1 − p
 n−i,( 1 )
where k =  (n/2).
Suppose nine independent predictors each with pre-
diction accuracy 0.65 are combined by majority votes, the
combined prediction accuracy becomes 0.83.
I2D [18] collects and maintains protein to protein
interaction from various sources and we have downloaded
the interaction information pertaining to Homo Sapiens.
By applying the majority votes, we have minimized some
plausible noise in the data set.
The microarray experiment was repeated three times
and in each repetition the expressions of genes under the
following two conditions are measured: (1) integrin negative
cell line (control), and (2) integrin positive cell line. Out of
the 22277 genes we have selected only 8512 genes that have
valid signal in all measurements. The average of the log ratio
between the integrin positive and the control expression in
all the repetitions is taken as the expression of a gene. From
the expressions, we could create diﬀerent expression patterns
based on the values such as up regulated fold changes over
2t o3 ,3t o4 ,a n do v e r4 .A m o n gt h ed o w nr e g u l a t e d
genes, we may have the similar groups. For simplicity, we
have taken only two patterns, namely, up regulated and
down regulated genes. The up regulated genes are those that
have fold changes (log of the ratio 2) over 1 and the down
regulatedarethosethathavethefoldchanges(logoftheratio
0.5) less than −1.
2.3. Methods. We have downloaded human protein to pro-
tein interaction networks from I2D, which have 13 560 genes
that have connectivity from 1 to 694. The connectivity or
degree of a node is deﬁned as the number of edges connected
to the network and we consider each edge as bidirectional
connection.Asexpected,theinteractionfollowsthescalefree
distribution. For the purpose of integrating the interaction
network with the microarray expression data set, we have
extracted a subnetworks from the whole networks that
interact with the diﬀerentially expressed genes from the
experiment. The selected sub networks, which we refer to as
G, have 2186 genes including the 190 diﬀerentially expressed
genes, and 3130 edges. A view of Graph G is shown in
Figure 1 as created by Navigator [19]. The up and down
regulated genes are shown in red and green, respectively, and
thesizeofeachnode correspondstothedegreeofinteraction
of that node in the graph.
In a typical microarray analysis, the diﬀerentially
expressed genes are ranked based on their fold changes and
the ﬁrst few of them as taken as important. We feel that using
expression fold change alone to determine the importance
o fag e n ei sq u i t ew e a k .W et a k ead i ﬀerent approach in this
paper for discovering a set of important genes under a given4 Journal of Biomedicine and Biotechnology
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Figure 1: A view of protein to protein interaction associated with the diﬀerentially expressed genes. We refer to this graph as G.
experimental condition. We create the subgraphs, say G, of
protein to protein interaction networks that is associated
with the diﬀerentially expressed genes from the microarray
experiment. It is generally believed that the connectivity of
nodes in G roughly reﬂects the importance of the gene in
the interaction [20]. We found that even the network G has
the property of a typical scale free network indicating only a
small fraction of the node has large connectivity.
2.3.1. Selecting a Set of Important Genes Based on Topological
Structure. In the recent work, Jeong et al. [20]a n dT w e
et al. [21] have suggested that essential proteins are over
represented among those proteins having high degree of
connectivity, which can be attributed to the central role
in mediating interactions among numerous, less connected
proteins. Hub nodes in an interaction network are deﬁned
as a set of nodes with very high degree of interaction with
neighbors and the corresponding threshold for connectivity
is deﬁned quite arbitrarily. Vallabhajosyula et al. [22]h a v e
studied the issue on selecting hub nodes and the impacts
on their functional signiﬁcance, but unfortunately they were
unable to provide and prescriptive deﬁnition or method on
selecting hub nodes. They, however, stated that the nodes
with relatively high degree of interaction are likely to have
very high functional signiﬁcance. In the literature, we found
that people have applied varying criteria in selecting the
threshold for hub nodes; for example, Batada et al. [23]h a v e
deﬁned hub nodes as those connect to over 90% or 95% of
the nodes in the network. Biasing from the ﬁnding in [22]
that the top few percentage of nodes with high degree of
interaction has better functional signiﬁcance, we selected the
hub nodes; those that are in the top 3% of the nodes ranked
based on the decreasing order of connectivity.
We also believe that important genes must also play a
role in the stability of the network, that is, removal of such
node will break the network into disconnected subnetworks.
An articulation node in a graph plays the role of connecting
or keeping the graph together and the removal of such node
separates the graph into subgraphs. Thus the hub genes that
play articulation role in an interaction network seem to have
more functional signiﬁcance.
A minimum spanning tree is acyclic graph that connects
all the nodes in a network such that the summation of cost in
all the edges is minimal and thus eliminates redundant paths
among the nodes. A node with high degree of connectivity
in minimum spanning tree will indeed play an important
role. In a protein interaction network the edge cost is taken
to be 1 and we construct a minimal spanning tree using
Kruskal’s algorithm [24]. We selected the hub nodes from
the minimum spanning tree and consider them as important
genes too.
As described above, three set of potentially important
nodes can be selected from the following diﬀerent methods:
(1) hub nodes from the interaction networks, (2) hub nodes
from the set of articulation nodes, and (3) hub nodes from
the minimum spanning tree. The nodes satisfying condition
2 are indeed a subset of those satisfying condition 1 and
hence we have only two distinct conditions, namely, 2 and
3. We deﬁne a set of important genes; those that satisfy either
conditions 2 or 3.Journal of Biomedicine and Biotechnology 5
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Figure 2: The minimum spanning tree of the network associated with cancer pathway genes. The backbone of the tree is shown. Up-and
down regulated genes are shown in red and green color.
2.3.2. Important Genes Based on Pathways and Interaction.
Pandey Lab at the Johns Hopkins University and the
Institute of Bioinformatics [25] maintains experimentally
determinedtencancersignalingpathwaysforHomoSapiens,
namely, EGFR1, TGF, beta Receptor, TNF, alpha/NF-kB,
α6β4 Integrin, ID, Hedgehog, Notch, Wnt, AR, and Kit
Receptor. We have obtained the genes in each of the ten
cancer pathways and extracted sub network, say Gp,f r o m
the interaction network that interacts with any genes in the
cancer pathway. The important nodes of Gp include the ones
from the three following methods or sources.
(1) Hub nodes of Gp.
(2) Hub nodes of the articulation nodes of Gp.
(3) Hub nodes of the minimum spanning tree created
from Gp.
The nodes satisfying condition 2 are indeed a subset
of those satisfying condition 1 and hence we have only
two distinct conditions, namely, 2 and 3. The important
nodes related to cancer pathway are those that satisfy either
condition 2 or 3.
Besidesexaminingtheimportantnodesineachgraph,we
can examine the cliques or near cliques for similar functional
association of genes. Han et al. [26] along with many other
researchershaveusedcliquesornearcliquesinaninteraction
network to ﬁnd functional group of genes. A clique is a fully
connected subgraph of a graph and ﬁnd cliques in a network
is computationally intractable. For many practical purposes,
near cliques are computed.
3. Results
From the microarray experiment, we have two diﬀerent
expression patterns, namely, up-and downregulated genes.
The up regulated genes are those that have valid signal across
three trials and have expression level over 2 times that of the
reference gene. Similarly the down regulated genes are those
that have valid signal across three trials and have inverse
expression level over 2 with respect to the reference gene.
We list the ﬁrst 14 up and down regulated genes of our
experiment in Table 1. We combined the gene expression
with gene interaction by selecting subset of the interaction
graph that associates with all the diﬀerentially expressed
genes. The selected subgraphs, which we refer to as G, have
2186 genes including the 190 diﬀerentially expressed genes,
and 3130 edges. Note that there is no single hub node among
the 14 high ranking up regulated nodes of G. On the other
hand, there are 5 hub nodes among the high ranking down
regulated nodes. There seems to be no correlation among the
hub nodes of an interacting graph with highly up or down
regulated genes.
From the graph G, we select the set of important genes
based on topological structure, which involves selecting the
hub nodes and following the procedures described in the
previous section. The cutoﬀ connectivity for the hub nodes
in G is 16 and there are 60 hub genes out of 2186 genes. Out
of the 60 hub nodes, 49 are from the diﬀerentially expressed
genes (12 of them are up regulated and the rest are down
regulated).ThegraphGhas200articulationgenesandoutof
which 60 satisfy the hub condition (degree 16 or above). The6 Journal of Biomedicine and Biotechnology
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Figure 3: The cliques or near cliques from the cancer pathway related network Gp. The up-and downregulated genes are shown in red and
green, respectively.
minimum spanning tree of G was constructed assuming the
edge cost is 1. The nodes with connectivity 9 or better in the
minimum spanning tree satisfy the hub node property. The
minimum spanning tree has 77 hub genes and out of which
17 of them are up regulated and 46 are down regulated. In
agreement with conditions 2 and 3 in Section 2,5 7g e n e sa r e
selected as important ones out of which 12 are up regulated
and 35 are down regulated. These genes are listed in Table 3.
To discover the important genes related to cancer, we
have extracted a sub network, which we call Gp,f r o m
Gs u c ht h a te a c hn o d ei nG p is directly associating with
any one of the genes in cancer pathways that include
EGFR1, TGF, beta Receptor, TNF, alpha/NF-kB, Alpha6
Beta4, Integrin, ID, Hedgehog, Notch, Wnt, AR, and Kit
Receptor pathways. The genes in these curated pathways
for human are downloaded from their web portal [25]. We
found 24 nodes in the network with connectivity 12 or
better satisfy the hub node property. The pathway related
network Gp h a s1 3 2a r t i c u l a t i o ng e n e so u to fw h i c h2 3a r e
hub genes. The minimum spanning tree of Gp is constructed
and the backbone of the minimum spanning tree is shown
in Figure 2. The minimum spanning tree has 200 genes and
17 out of these genes have connectivity 4 or better satisfy the
hub node property. By combining all these three set of hub
genesusingensemblemethod,wehavecreatedtheimportant
genes related to pathways and are presented in Table 4.
Besides examining the important genes in Gp, the cancer
pathway related network, we searched for cliques or near
cliques in the network to examine functionally related genes.
The cliques from the network Gp is shown in Figure 3.
Let us examine the interaction among important genes
based on topological structure (from Table 3) and between
the highly expressed genes from Table 1. The interaction is
shown in Figure 4.
The direct interaction among the genes identiﬁed as
importantnodesduetotheknowncancerpathwaysisshown
in Figure 5.
4. Summary andDiscussion
In this paper we have presented a general method for inte-
grating microarray expression with other complementary
information related to gene function so that we can under-
stand and infer information about the set of genes that we
are interested. Particularly we focused on integrating protein
interaction information and pathway related information
with microarray expression. We have applied the proposed
general methodology to our recent microarray experiment
to discover potential drug target that may lead to novel
anticancer therapeutics.
Quite a large body of research works is done in
integrating expression data with interaction network and
other data sets. Many of the works fall into one or some
combination of the following categories: (1) annotating
uncharacterized genes, (2) reﬁning protein to protein inter-
action network, (3) predicting protein to protein interaction,
and (4) reﬁning potential biomarkers from array expression.
The presented work here has some overlaps with the recent
work of Camargo et al. [2], which involved in integrating
expression data set with expression data set for reﬁning
potential biomarkers of array expression and to annotate
uncharacterized genes. They have used hub genes of the
interaction network to reﬁne biomarkers of the expression
data sets.
The interaction network of Homo sapiens is scale free,
that is there are few nodes having very high degree of
interaction and facilitate other nodes in mediating their
functions. Even the subnetwork of the interaction networkJournal of Biomedicine and Biotechnology 7
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Figure 4: The interaction between the top 14 up regulated genes from Table 1 with the set of important genes based on network topology
(Table 3). The red one represents the gene from Table 1. The green colored ones are down regulated and the red and purple ones are up
regulated.
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Figure 5: The interaction between the top 14 up regulated genes from Table 1 with the set of important genes based on pathway (Table 4).
The red one represents the gene from Table 1. The green colored ones are down regulated and the red and purple ones are up regulated.
that has direct interaction with diﬀerentially expressed genes
is found to be having the properties of scale free network.
Hub nodes in an interaction network are deﬁned as a set of
nodes with very high degree of interaction with neighbors
and the corresponding threshold for connectivity is deﬁned
quite arbitrarily. Biasing from the ﬁnding in [22] that the
top few percentage of nodes with high degree of interaction
has better functional signiﬁcance, we selected the hub nodes;
those that are in the top 3% of the nodes ranked based on the
decreasing order of connectivity.
From the Homo sapiens interaction network, we have
extracted a sub network called G that is associated with the
diﬀerential expressed genes of our microarray experiment.
Hub nodes in an interaction network are important and we
selectedtheﬁrstsetofhubnodesfromG.Asetofarticulation
nodes, which plays the role of stability of the network, is also
important.WeselectedasetofarticulationnodesfromG.We
have constructed a minimum spanning tree from G and we
haveselectedasetofhubnodesfromtheminimumspanning
tree. We created important set of genes based on topological8 Journal of Biomedicine and Biotechnology
Table 3: The important set of genes based on topological structure
of interaction network. Selecting the nodes that satisfy condition 2
(the articulation nodes among the hub nodes of the network) and
condition 3 (the hub nodes of the minimum spanning tree). The
inverse of fold changes for down regulated genes is shown. Thus the
table includes the genes that are not considered in the experiment
or neither up-or downregulated.
Gene Regulation Fold change
CPNE1 Up 2.63
CTSB Up 2.78
CTSD Up 2.00
MAD1L1 Up 3.45
MEF2C Up 2.21
PCM1 Up 2.01
PRKAR2B Up 2.80
PSMD7 Up 2.01
PTPN1 Up 2.06
RBL2 Up 2.62
RGS20 Up 2.20
SOD2 Up 2.10
ADSL Down 2.23
ATM Down 2.09
BID Down 2.09
CASP1 Down 3.07
CBLB Down 2.32
CCNB2 Down 2.32
CDC7 Down 2.17
CHEK1 Down 2.06
CTTN Down 2.63
DDX17 Down 2.13
DGCR14 Down 2.04
ETS1 Down 2.50
FOS Down 2.94
GLUL Down 5.13
GNAQ Down 2.39
ID2 Down 2.86
MACF1 Down 2.05
MRE11A Down 2.61
MYLK Down 4.25
NEDD4 Down 2.01
PAFAH1B2 Down 2.57
PPFIA1 Down 2.41
PRKAB2 Down 2.56
PRSS23 Down 2.47
RAB27A Down 2.74
RAB8B Down 2.27
RPL31 Down 2.08
RRM2 Down 2.32
SMARCB1 Down 2.14
SNCA Down 5.24
TGFB2 Down 2.06
THBS1 Down 3.70
Table 3: Continued.
Gene Regulation Fold change
TNFRSF1A Down 2.13
TPM1 Down 4.62
XRCC6 Down 2.08
DDX19B Down 2.09
∗GRINL1B — —
∗HIST2H3PS2 — —
∗NA — —
∗RET — —
∗RPL35A — —
∗∗SMC2 — —
∗∗SMC4 — —
∗∗TPI1 — —
∗∗TUBA4A — —
∗These genes are neither up-or downregulated, nor considered in the
experiment.
∗∗These genes are from interaction network that satisfy conditions 2 and 3.
Table 4: The important genes of network associated with genes
in cancer pathways. These genes are obtained by combining three
sets of hub genes from interaction network, articulation nodes,
and from the minimum spanning tree of Gp. We show the speciﬁc
pathway a gene is involved with.
Genes Regulation Pathway
CTSB Up
CTSD Up Tgf beta,ar
PSMD7 Up
PTPN1 Up
RBL2 Up Tgf beta
SOD2 Up Tnf alpha
ATM Down
BID Down Tnf alpha
CASP1 Down Tnf beta
CBLB Down
CCNB2 Down Tgf beta
CHEK1 Down
ETS1 Down Tgf beta,tnf alpha
FOS Down Wnt,ar,kit
GRB10 Down ar
ID2 Down Tgf beta,ar
MRE11A Down
NEDD4 Down Tgf beta
RRM2 Down Egfr1
SNCA Down
TGFB2 Down Egfr1,tgf beta,tnf alpha,ar
THBS1 Down Tgf beta, tnf alpha, id,wnt
TNFRSF1A Down Tgf beta,notch,kit
XRCC6 DownJournal of Biomedicine and Biotechnology 9
structure of the interaction network. The hub nodes alone in
isolation do not reveal any useful information. Similarly the
highly ranked up or down regulated genes by themselves do
not provide any clue into any potential signaling pathways
either.
On the other hand, when we combine the set of
important genes based on the interaction topology from
Table 3 andthesetofhighlyexpressedgenesfromTable 1,we
started to get some insight into potential signal transduction
patternasshowninFigure 4.Thehighlyexpressedgenefrom
the experiment NRCAM, neuronal cell adhesion molecule,
is directly interacting with another gene NA (neurocantho-
cytosis) which is recognized as an important gene from the
topologyandmediatingthedownregulationofthefollowing
set of tumor suppression genes, CHEK1 [27], XRCC6 [28],
SMARCB [29], and ATM [30] .T h eg e n eN Aa c t sa sa
hub gene among the set of important genes and it directly
interactswithSMARCBandXRCC4,whichdirectlyinteracts
with CHEK1 which in turn directly interacting with ATM. It
is notable that down regulation of these tumor suppressor
genes by integrin α6β4 has a signiﬁcant implication in
cancer biology. Poor prognosis has been associated with
over expression of integrin α6β4 and our analysis revealed
that loss of these tumor suppressor genes could attribute to
malignant phenotype of cancer cells.
Impact of this study lies in the identiﬁcation and
targetingmolecularaberrationsspeciﬁctocancercells.Many
recent studies with targeting a single agent turned out to be
a disappointment. This could partly be due to the inability
to identify signaling network or loop which is positively or
negatively regulated around the single target. To meet this
important challenge, a number recent studies are analyzing
cancer cell lines and tissue samples to measure alterations
at the gene, RNA, and protein level to identify markers and
targets for the therapy. While these studies will produce a
large amount of data whose analysis is critical in order to
understand cancer at the molecular level. For example, a
similar microarray analysis of MDA-MB-435 cells that are
engineered to diﬀer in integrin α6β4 expression by Chen
et al. leads to the identiﬁcation of couple of invasion and
metastasis related genes such as ENPP2 [31] and S100A4
[32]. What makes our study unique from these works is
that we are in a position to identify genes and proteins
thatarefunctionallyconnectedtodrivemalignantproperties
rather than focusing a single gene because targeting these
sub networks will inhibit cancer cell functions important
for progression. For example, we found the potentially
important α6β4 target genes associated with cancer pathway
as summarized in Table 4. Those genes are associated with
TGF-β [33], TNF-α [34], and EGFR1 pathways [35], whose
roles in cancer progression have been well established.
In summary, the integration of interaction network with
expression of α6β4 integrin in MDA-MB-435 cancer cells
revealstheimportanceofNRCAM,whichwewouldnothave
discovered with the expression information alone. Further,
the interaction network in Figure 4 helps us to under-
stand how the tumor suppression genes CHEK1, XRCC6,
SMARCB, ATM, CHEK1 were down regulated by integrin
α6β4. Finally, we envision the discovery of interaction
network triggered from tumor antigen such as integrin α6β4
will lead to the development of novel anticancer therapeutics
by targeting signaling molecules associated with interaction
network.
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